Efficacy and safety of trastuzumab deruxtecan therapy
Antibody-drug conjugates (ADCs) are a new generation of drugs that currently represent one of the most effective treatment options for cancer. ADCs target a specific target (antigen) that is selectively expressed on a tumour cell. Binding of ADCs to a tumour cell results in targeted intracellular d...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Slovenian |
| Published: |
Institute of Oncology Ljubljana
2024-12-01
|
| Series: | Onkologija |
| Subjects: | |
| Online Access: | https://revijaonkologija.si/Onkologija/article/view/561 |